{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:57:44Z","timestamp":1790524664948,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejso.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T10:33:02Z","timestamp":1485685982000},"page":"1228-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival"],"prefix":"10.1016","volume":"43","author":[{"given":"P.H.","family":"Sugarbaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2017.01.009_bib1","series-title":"Peritoneal carcinomatosis: drugs and diseases","first-page":"193","article-title":"Peritoneal mesothelioma: treatment approach based on natural history","author":"Averbach","year":"1996"},{"issue":"3","key":"10.1016\/j.ejso.2017.01.009_bib2","first-page":"174","article-title":"Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma","volume":"3","author":"Ma","year":"1997","journal-title":"Cancer J Sci Am"},{"issue":"6","key":"10.1016\/j.ejso.2017.01.009_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10434-999-0582-6","article-title":"Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP)","volume":"6","author":"Park","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.01.009_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/026765919901400208","article-title":"Treatment of primary peritoneal mesothelioma by hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Mongero","year":"1999","journal-title":"Perfusion"},{"issue":"10","key":"10.1016\/j.ejso.2017.01.009_bib5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","article-title":"Prospective trial for the treatment of malignant peritoneal mesothelioma","volume":"67","author":"Loggie","year":"2001","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.01.009_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","article-title":"A\u00a0review of peritoneal mesothelioma at the Washington Cancer Institute","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"24","key":"10.1016\/j.ejso.2017.01.009_bib7","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2017.01.009_bib8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21239","article-title":"Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution","volume":"104","author":"Nonaka","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2017.01.009_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","article-title":"Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study","volume":"13","author":"Brigand","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2017.01.009_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","article-title":"Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy","volume":"31","author":"Elias","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"issue":"9","key":"10.1016\/j.ejso.2017.01.009_bib11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma","volume":"35","author":"Yano","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A\u00a0systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.01.009_bib13","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2017.01.009_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/annonc\/mdl060","article-title":"Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference","volume":"17","author":"Hassan","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.01.009_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","article-title":"Consensus statement on peritoneal mesothelioma","volume":"98","author":"Deraco","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib16","unstructured":"International PSOGI Registry on Peritoneal Mesothelioma. Accessible at http:\/\/test.dinamoweb.net\/p_mesotelioma\/."},{"issue":"11","key":"10.1016\/j.ejso.2017.01.009_bib17","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","article-title":"Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma","volume":"130","author":"Cerruto","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.ejso.2017.01.009_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","article-title":"Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion","volume":"13","author":"Deraco","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.20836","article-title":"Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"15","author":"Yan","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2017.01.009_bib20","first-page":"49","article-title":"Current methodologies for clinical assessment of patients with peritoneal carcinomatosis","volume":"15","author":"Jacquet","year":"1996","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2017.01.009_bib21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","article-title":"Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.01.009_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","article-title":"Lymph node metastases in diffuse malignant peritoneal mesothelioma","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.01.009_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","article-title":"Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma \u2013 a prospective study of 70 consecutive cases","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.01.009_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jso.21388","article-title":"Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies","volume":"100","author":"Deraco","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.01.009_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study","volume":"19","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib27","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","first-page":"1","article-title":"An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy","author":"Sugarbaker","year":"2012"},{"key":"10.1016\/j.ejso.2017.01.009_bib28","series-title":"Peritoneal carcinomatosis: principles of management","first-page":"415","article-title":"A\u00a0simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","author":"Sugarbaker","year":"1996"},{"key":"10.1016\/j.ejso.2017.01.009_bib29","article-title":"Pharmacokinetic study of perioperative intravenous ifosfamide","volume":"2011","author":"Van der Speeten","year":"2011","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2017.01.009_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1055-3207(03)00038-3","article-title":"Intraperitoneal taxanes","volume":"12","author":"Mohamed","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejso.2017.01.009_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/752643","article-title":"Adjuvant bidirectional chemotherapy using an intraperitoneal port","volume":"2012","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2017.01.009_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/890450","article-title":"Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous cisplatin for diffuse malignant peritoneal mesothelioma","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"26","key":"10.1016\/j.ejso.2017.01.009_bib33","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2017.01.009_bib34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2017.01.009_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2017.01.009_bib36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I","article-title":"Evaluation of computer tomography in patients with peritoneal carcinomatosis","volume":"72","author":"Jacquet","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2017.01.009_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.01.009_bib38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1245\/s10434-014-3977-y","article-title":"Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal metastases: clinicopathologic characteristics and survival outcome","volume":"22","author":"Ihemelandu","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.01.009_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00280-003-0680-2","article-title":"Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions","volume":"52","author":"Mohamed","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.ejso.2017.01.009_bib40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JOP.2016.011908","article-title":"Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy","volume":"12","author":"Sugarbaker","year":"2016","journal-title":"J\u00a0Oncol Pract"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317300598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317300598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:04:13Z","timestamp":1692662653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317300598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0748798317300598"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.01.009","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}